Koen J C van der Mijn - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Neoplasia (New York, N.Y.)|November 16, 2010

Phase 1/2 study of atrasentan combined with pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancerPetronella O Witteveen, Koen J C van der Mijn, Maartje Los, et al.

European Urology|June 4, 2023

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.

Cancers|June 10, 2023

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment OptionsLotte G Zuur, Hilda A de Barros, Koen J C van der Mijn, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Neoplasia (New York, N.Y.)|November 16, 2010

Phase 1/2 study of atrasentan combined with pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancerPetronella O Witteveen, Koen J C van der Mijn, Maartje Los, et al.

European Urology|June 4, 2023

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor-driven ProgramsSimon Linder, Tesa M Severson, Koen J C van der Mijn, et al.

Cancers|June 10, 2023

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment OptionsLotte G Zuur, Hilda A de Barros, Koen J C van der Mijn, et al.

Pageof 1